Logo Prima Biomed


Welcome to the Newsroom

01 November 2017

Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017


ENGLISH

 

SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer and Medical Officer, gave an oral presentation at the World Immunotherapy Congress 2017 in Basel, Switzerland at 5.50pm CEST on October 31, 2017.

 

(...)